TOP TIERMARKET NEWSWIRE
News & sentiment

NEUROCRINE BIOSCIENC (NBIX) — News & AI sentiment

NEUROCRINE BIOSCIENC (NBIX) news roundup. 5 stories in the past week, 11 over 30 days. Average 30-day sentiment is 58.1/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $7.5M — net selling of $7.5M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 56/100
30d stories
11
avg sentiment 58.1/100
Insider net (90d)
$7.5M
0 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

NBIX news in the last 24 hours, 7 days, 30 days and 90 days

How much NBIX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowNBIX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days556/100NBIX headlines →
Last 30 days1158.1/100NBIX headlines →
Last 90 days5358.1/100NBIX headlines →

Latest stories on NBIX

2d ago
3d ago
4d ago
4d ago
Neurocrine Biosciences stock rating reaffirmed by RBC Capital
Investing.com Analyst Ratings50 · neutralanalyst
5d ago
Sep 3
Sep 2
Aug 26
Neurocrine Biosciences: 'House Full Of Options'
Seeking Alpha67 · bullishanalyst
Aug 22
Aug 17
Aug 17
Aug 12
Why is Neurocrine Biosciences stock sliding today?
Investing.com Markets42 · neutralgeneral
Aug 12
Aug 12
Neurocrine Biosciences stock falls on Vykat safety concerns
Investing.com Markets38 · neutralgeneral
Aug 12
Aug 12
Aug 12
Aug 12
Why is Neurocrine Biosciences stock down today?
Investing.com Markets50 · neutralgeneral
Aug 12
Aug 7
Aug 7
Aug 7
Neurocrine (NBIX) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Aug 3
Aug 3
Canaccord raises Neurocrine Bio price target on strong sales beat
Investing.com Analyst Ratings61 · neutralanalyst
Aug 3
Open NBIX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →